David Ramsay
Director/Board Member at SAVARA INC.
Net worth: 10 M $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Gregory Ian Frost | M | 52 |
EXUMA Biotech Corp.
 EXUMA Biotech Corp. Miscellaneous Commercial ServicesCommercial Services EXUMA Biotech Corp. engages in the biotechnology business. The company was founded in November 2015 and is headquartered in West Palm Beach, FL. | 17 years |
| Matthew Pauls | M | 53 |
Mast Therapeutics, Inc.
 Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | 9 years |
| Michael Hearne | M | 61 | 4 years | |
| Connie Matsui | F | 70 | 18 years | |
| Helen Torley | M | 61 | 10 years | |
| Nicole LaBrosse | F | 41 | 9 years | |
| Anne Erickson | F | - | 6 years | |
| David Lowrance | M | 56 | 7 years | |
| Michael LaBarre | M | 60 | 16 years | |
| Joseph McCracken | M | 71 | 7 years | |
| Susan Abushakra | M | 63 |
Bonti, Inc.
 Bonti, Inc. Pharmaceuticals: MajorHealth Technology Bonti, Inc. develops novel treatments. It specializes in both aesthetic and therapeutic indications. The company was founded by Fauad Hasan, Mike Jarpe, Wajdie Ahmad, Jonathan Lim, David Ramsay and Susan Abushakra in 2015 and is headquartered in Newport Beach, CA. | 9 years |
| Mike Jarpe | M | - |
Bonti, Inc.
Bonti, Inc. Pharmaceuticals: MajorHealth Technology Bonti, Inc. develops novel treatments. It specializes in both aesthetic and therapeutic indications. The company was founded by Fauad Hasan, Mike Jarpe, Wajdie Ahmad, Jonathan Lim, David Ramsay and Susan Abushakra in 2015 and is headquartered in Newport Beach, CA. | 9 years |
| An van Es-Johansson | M | 64 | 5 years | |
| Wajdie Ahmad | M | - |
Bonti, Inc.
Bonti, Inc. Pharmaceuticals: MajorHealth Technology Bonti, Inc. develops novel treatments. It specializes in both aesthetic and therapeutic indications. The company was founded by Fauad Hasan, Mike Jarpe, Wajdie Ahmad, Jonathan Lim, David Ramsay and Susan Abushakra in 2015 and is headquartered in Newport Beach, CA. | 9 years |
| Ricky Sun | M | 50 | 5 years | |
| Matthew Posard | M | 56 | 11 years | |
| Nevan Elam | M | 56 | 15 years | |
| Richard Hawkins | M | 75 | 14 years | |
| Frank McCormick | M | - |
EXUMA Biotech Corp.
EXUMA Biotech Corp. Miscellaneous Commercial ServicesCommercial Services EXUMA Biotech Corp. engages in the biotechnology business. The company was founded in November 2015 and is headquartered in West Palm Beach, FL. | - |
| Pavel Raifeld | M | 40 | 2 years | |
| Kate McCabe | F | - | 6 years | |
| Tony Hodges | M | - | 3 years | |
| Houston Holmes | M | - |
EXUMA Biotech Corp.
EXUMA Biotech Corp. Miscellaneous Commercial ServicesCommercial Services EXUMA Biotech Corp. engages in the biotechnology business. The company was founded in November 2015 and is headquartered in West Palm Beach, FL. | - |
| Paula Rusu | F | - | 4 years | |
| Raymond Pratt | M | 73 | 2 years | |
| Robert M. Lutz | M | 55 | 1 years | |
| Marianne Zhen | F | 55 | 2 years | |
| Scott Segal | M | 69 |
EXUMA Biotech Corp.
EXUMA Biotech Corp. Miscellaneous Commercial ServicesCommercial Services EXUMA Biotech Corp. engages in the biotechnology business. The company was founded in November 2015 and is headquartered in West Palm Beach, FL. | - |
| Donald A. McQuade | M | 82 |
University of California, Berkeley
| 38 years |
| Scott Wilhoit | M | 61 | 1 years | |
| Peter M. Clarke | M | 64 | 3 years | |
| Steven Frank | M | 64 |
EXUMA Biotech Corp.
EXUMA Biotech Corp. Miscellaneous Commercial ServicesCommercial Services EXUMA Biotech Corp. engages in the biotechnology business. The company was founded in November 2015 and is headquartered in West Palm Beach, FL. | 4 years |
| Olivia Mitchell | F | 71 |
The Wharton School of the University of Pennsylvania
| 31 years |
| Gregory R. Wade | M | 55 |
EXUMA Biotech Corp.
EXUMA Biotech Corp. Miscellaneous Commercial ServicesCommercial Services EXUMA Biotech Corp. engages in the biotechnology business. The company was founded in November 2015 and is headquartered in West Palm Beach, FL. | 3 years |
| Charles LaPree | M | - | 3 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Patrick Keran | M | 52 |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | 9 years |
| Jonathan Lim | M | 52 |
Bonti, Inc.
Bonti, Inc. Pharmaceuticals: MajorHealth Technology Bonti, Inc. develops novel treatments. It specializes in both aesthetic and therapeutic indications. The company was founded by Fauad Hasan, Mike Jarpe, Wajdie Ahmad, Jonathan Lim, David Ramsay and Susan Abushakra in 2015 and is headquartered in Newport Beach, CA. | 11 years |
| Brandi Roberts | F | 50 |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | 6 years |
| George Tidmarsh | M | 64 | 7 years | |
| Kathryn Falberg | F | 63 | 9 years | |
| Peter Greenleaf | M | 54 |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | - |
| Harry Leonhardt | M | 67 | 5 years | |
| Dennis Mulroy | M | 69 | 5 years | |
| Kenneth Kelley | M | 64 | 17 years | |
| Howard C. Dittrich | M | 71 |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | 3 years |
| Fauad Hasan | M | - |
Bonti, Inc.
Bonti, Inc. Pharmaceuticals: MajorHealth Technology Bonti, Inc. develops novel treatments. It specializes in both aesthetic and therapeutic indications. The company was founded by Fauad Hasan, Mike Jarpe, Wajdie Ahmad, Jonathan Lim, David Ramsay and Susan Abushakra in 2015 and is headquartered in Newport Beach, CA. | - |
| Larry G. Edwards | M | 52 | 3 years | |
| Kurt Gustafson | M | 56 | 4 years | |
| Jean Bizzari | M | 69 | 9 years | |
| James Daly | M | 63 | 8 years | |
| Robert Engler | M | 79 | 11 years | |
| James E. Cartoni | M | - | 3 years | |
| Pierre Breber | M | 59 |
University of California, Berkeley
| 5 years |
| Ray Salomon | M | 61 |
University of California, Berkeley
| 7 years |
| Robert H. Rosen | M | 68 | 8 years | |
| Michael J. Estrada | M | - |
University of California, Berkeley
| 3 years |
| Edwin L. Parsley | M | 63 |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | - |
| Wei-Tek Tsai | M | 64 |
University of California, Berkeley
| 5 years |
| Justin Warren Slatky | M | - |
The Wharton School of the University of Pennsylvania
| 5 years |
| Richard G. Wallace | M | - |
University of California, Berkeley
| 7 years |
| Laura Douglass | F | 59 | 9 years | |
| Jim Mazzola | M | - | 3 years | |
| Matthew Young | M | 54 |
The Wharton School of the University of Pennsylvania
| 5 years |
| Cecilia Ganslandt | M | - | 5 years | |
| Fabio Selmoni | M | - |
The Wharton School of the University of Pennsylvania
University of California, Berkeley
| 7 years |
| Jennifer Carver | F | 70 | 5 years | |
| Carl Perez | M | - |
University of California, Berkeley
| 8 years |
| Sandra Vedrick | F | - | 6 years | |
| Kamal H. Khayat | M | - |
University of California, Berkeley
| 3 years |
| Taneli Jouhikainen | M | 57 | 3 years | |
| Larry Nan-lei Wang | M | - |
University of California, Berkeley
| 4 years |
| Walter H. Bee | M | - | - | |
| William J. Fallon | M | - | 14 years | |
| Jean Liu | F | 55 | 3 years | |
| Brian Culley | M | 53 | - | |
| Alan P. Heim | M | 71 |
Lathian Systems, Inc.
 Lathian Systems, Inc. Advertising/Marketing ServicesCommercial Services Lathian Systems, Inc. provides technology-based sales and marketing solutions for the life science industry. It revolutionized the way the Internet is used for online pharmaceutical marketing and non-personal promotion to physicians and healthcare providers (HCPs). Lathian provides data products and physician insights, electronic marketing services such as eDetailing, and sales solutions that enable brand teams to augment traditional sales force activities, reach more physicians, and increase sales. The company was founded in 1999 and is headquartered in Blue Bell, PA | 6 years |
| Jonathan Leff | M | 66 | 1 years | |
| Lewis J. Shuster | M | 68 |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | 5 years |
| Robert Norman Neville | M | 58 | 3 years | |
| John Stuart Patton | M | 77 | 25 years | |
| Randy Meier | M | 65 |
Bausch Health Americas, Inc.
 Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | 4 years |
| Jack Lief | M | 78 |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | 9 years |
| Andreas C. Cangellaris | M | - |
University of California, Berkeley
| 3 years |
| Ted Love | M | 65 |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | 1 years |
| Andrew Pearson | M | 52 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Phil Bronner | M | 53 |
The Wharton School of the University of Pennsylvania
| 3 years |
| Weijian Shan | M | 70 |
The Wharton School of the University of Pennsylvania
University of California, Berkeley
| 10 years |
| Yuri Pikover | M | 62 | 6 years | |
| Craig Johnson | M | 62 | 9 years | |
| Greg Brogger | M | 55 |
The Wharton School of the University of Pennsylvania
University of California, Berkeley
| 9 years |
| Thomas E. Tighe | M | - |
University of California, Berkeley
| 7 years |
| Maja M. Gross | F | - |
The Wharton School of the University of Pennsylvania
| 6 years |
| Randal Kirk | M | 70 | 11 years | |
| Shana C. Hood | F | - | - | |
| Stockton Croft | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| Darryl Smith | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| Reid Schneider | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Andrie Setiawan Yapsir | M | 64 |
The Wharton School of the University of Pennsylvania
| 2 years |
| Scott Blakeman | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Jor Law | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- David Ramsay
- Personal Network